相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of 6-month treatment with the glucagon like peptide-1 analogue liraglutide on arterial stiffness, left ventricular myocardial deformation and oxidative stress in subjects with newly diagnosed type 2 diabetes
Vaia Lambadiari et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Linagliptin improves endothelial function in patients with type 2 diabetes: A randomized study of linagliptin effectiveness on endothelial function
Fumika Shigiyama et al.
JOURNAL OF DIABETES INVESTIGATION (2017)
Effect of Saxagliptin on Circulating Endothelial Progenitor Cells and Endothelial Function in Newly Diagnosed Type 2 Diabetic Patients
Fang Li et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2017)
The efficacy and safety of adding either vildagliptin or glimepiride to ongoing metformin therapy in patients with type 2 diabetes mellitus
Gyuri Kim et al.
EXPERT OPINION ON PHARMACOTHERAPY (2017)
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Detecting human coronary inflammation by imaging perivascular fat
Alexios S. Antonopoulos et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Impact of DPP-4 inhibition on acute and chronic endothelial function in humans with type 2 diabetes on background metformin therapy
Michael E. Widlansky et al.
VASCULAR MEDICINE (2017)
Microangiopathy, Arterial Stiffness, and Risk Stratification in PatientsWith Type 2 Diabetes
Alexios S. Antonopoulos et al.
JAMA CARDIOLOGY (2017)
Long-term Saxagliptin Treatment Improves Endothelial Function but not Pulse Wave Velocity and Intima-Media Thickness in Type 2 Diabetic Patients
Raffaella Dell'Oro et al.
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION (2017)
Dapagliflozin acutely improves endothelial dysfunction, reduces aortic stiffness and renal resistive index in type 2 diabetic patients: a pilot study
Anna Solini et al.
CARDIOVASCULAR DIABETOLOGY (2017)
The effects of vildagliptin compared with metformin on vascular endothelial function and metabolic parameters: a randomized, controlled trial (Sapporo Athero-Incretin Study 3)
Naoyuki Kitao et al.
CARDIOVASCULAR DIABETOLOGY (2017)
Effects of the Selective Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin on Vascular Function and Central Hemodynamics in Patients With Type 2 Diabetes Mellitus
Kristina Striepe et al.
CIRCULATION (2017)
The molecular mechanisms of obesity paradox
Alexios S. Antonopoulos et al.
CARDIOVASCULAR RESEARCH (2017)
Effect of linagliptin on pulse wave velocity in early type 2 diabetes: A randomized, double-blind, controlled 26-week trial (RELEASE)
Stefanie A. de Boer et al.
DIABETES OBESITY & METABOLISM (2017)
Effectiveness of dapagliflozin on vascular endothelial function and glycemic control in patients with early-stage type 2 diabetes mellitus: DEFENCE study
Fumika Shigiyama et al.
CARDIOVASCULAR DIABETOLOGY (2017)
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i): Their Role in Cardiometabolic Risk Management
Niki Katsiki et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
A randomised, active- and placebo-controlled, three-period crossover trial to investigate short-term effects of the dipeptidyl peptidase-4 inhibitor linagliptin on macro- and microvascular endothelial function in type 2 diabetes
Thomas Jax et al.
CARDIOVASCULAR DIABETOLOGY (2017)
Effect of trelagliptin on vascular endothelial functions and serum adiponectin level in patients with type 2 diabetes: a preliminary single-arm prospective pilot study
Satoshi Ida et al.
CARDIOVASCULAR DIABETOLOGY (2016)
Long-term effect of sitagliptin on endothelial function in type 2 diabetes: a sub-analysis of the PROLOGUE study
Tatsuya Maruhashi et al.
CARDIOVASCULAR DIABETOLOGY (2016)
Clinical Update: Cardiovascular Disease in Diabetes Mellitus Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations
Cecilia C. Low Wang et al.
CIRCULATION (2016)
Effects of dipeptidyl peptidase-4 inhibitors on cardiac and endothelial function in type 2 diabetes mellitus: A pilot study
Melissa Leung et al.
DIABETES & VASCULAR DISEASE RESEARCH (2016)
Effects of Dipeptidyl Peptidase 4 Inhibitors and Sodium-Glucose Linked coTransporter-2 Inhibitors on cardiovascular events in patients with type 2 diabetes mellitus: A meta-analysis
Gianluigi Savarese et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Effect of Linagliptin on Vascular Function: A Randomized, Placebo-controlled Study
Dimitrios Baltzis et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Effects of dipeptidyl peptidase-4 inhibitors on blood pressure in patients with type 2 diabetes: A systematic review and meta-analysis
Xiaodan Zhang et al.
JOURNAL OF HYPERTENSION (2016)
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Dipeptidyl peptidase-4 inhibitors improve arterial stiffness, blood pressure, lipid profile and inflammation parameters in patients with type 2 diabetes mellitus
Lea Duvnjak et al.
DIABETOLOGY & METABOLIC SYNDROME (2016)
A Randomized Controlled Trial Comparing the Effects of Sitagliptin and Glimepiride on Endothelial Function and Metabolic Parameters: Sapporo Athero-Incretin Study 1 (SAIS1)
Hiroshi Nomoto et al.
PLOS ONE (2016)
Effects of Short-Term Exenatide Treatment on Regional Fat Distribution, Glycated Hemoglobin Levels, and Aortic Pulse Wave Velocity of Obese Type 2 Diabetes Mellitus Patients
Ju-Young Hong et al.
ENDOCRINOLOGY AND METABOLISM (2016)
Arterial Wall Elastic Properties and Endothelial Dysfunction in the Diabetic Foot Syndrome in Patients With Type 2 Diabetes
Alexios S. Antonopoulos et al.
DIABETES CARE (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
Jennifer B. Green et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
Marc A. Pfeffer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Adiponectin as a Link Between Type 2 Diabetes and Vascular NADPH Oxidase Activity in the Human Arterial Wall: The Regulatory Role of Perivascular Adipose Tissue
Alexios S. Antonopoulos et al.
DIABETES (2015)
A Comparison of the Effects of the GLP-1 Analogue Liraglutide and Insulin Glargine on Endothelial Function and Metabolic Parameters: A Randomized, Controlled Trial Sapporo Athero-Incretin Study 2 (SAIS2)
Hiroshi Nomoto et al.
PLOS ONE (2015)
DPP-4 inhibitor and alpha-glucosidase inhibitor equally improve endothelial function in patients with type 2 diabetes: EDGE study
Kazufumi Nakamura et al.
CARDIOVASCULAR DIABETOLOGY (2014)
GLP-1 Agonist Therapy for Advanced Heart Failure With Reduced Ejection Fraction Design and Rationale for the Functional Impact of GLP-1 for Heart Failure Treatment Study
Kenneth B. Margulies et al.
CIRCULATION-HEART FAILURE (2014)
Evaluation of exenatide versus insulin glargine for the impact on endothelial functions and cardiovascular risk markers
Eren Gurkan et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2014)
Effect of vildagliptin on hsCRP and arterial stiffness in patients with type 2 diabetes mellitus
Ioanna Zografou et al.
Hormones-International Journal of Endocrinology and Metabolism (2014)
Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes
Rury R. Holman et al.
LANCET (2014)
Dipeptidyl Peptidase-4 Inhibitor, Sitagliptin, Improves Endothelial Dysfunction in Association With Its Anti-Inflammatory Effects in Patients With Coronary Artery Disease and Uncontrolled Diabetes
Junichi Matsubara et al.
CIRCULATION JOURNAL (2013)
Exenatide improves endothelial function assessed by flow mediated dilation technique in subjects with type 2 diabetes: Results from an observational research
Concetta Irace et al.
DIABETES & VASCULAR DISEASE RESEARCH (2013)
Effects of 6 months glucagon-like peptide-1 receptor agonist treatment on endothelial function in type 2 diabetes mellitus patients
N. D. Hopkins et al.
DIABETES OBESITY & METABOLISM (2013)
Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
William B. White et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
Benjamin M. Scirica et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Dipeptidyl Peptidase-4 Inhibitors Attenuate Endothelial Function as Evaluated by Flow-Mediated Vasodilatation in Type 2 Diabetic Patients
Makoto Ayaori et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
The Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Improves Vascular Endothelial Function in Type 2 Diabetes
Yoshiaki Kubota et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2012)
Rapid, Direct Effects of Statin Treatment on Arterial Redox State and Nitric Oxide Bioavailability in Human Atherosclerosis via Tetrahydrobiopterin-Mediated Endothelial Nitric Oxide Synthase Coupling
Charalambos Antoniades et al.
CIRCULATION (2011)
Preoperative Atorvastatin Treatment in CABG Patients Rapidly Improves Vein Graft Redox State by Inhibition of Rae1 and NADPH-Oxidase Activity
Charalambos Antoniades et al.
CIRCULATION (2010)
Global estimates of the prevalence of diabetes for 2010 and 2030
J. E. Shaw et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
N. Sarwar et al.
LANCET (2010)
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
Steven E. Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
分享论文
